Cellomics, Inc. announces the creation of a Center of Excellence
Pittsburgh, PA – December 3, 2003 – Cellomics, Inc., the world’s first and leading producer of tools for High Content Screening (HCS) announced today the establishment of a Center of Excellence for HCS at the Cellomics, Inc. Headquarters in Pittsburgh, PA. According to Cellomics CEO, Dan Calvo, the center will be staffed by a team of scientists who have been instrumental in the establishment of HCS applications and protocols, both in industry and academia.
“The mission of the Center will be to advance the science of cellomics and HCS through education, training and application development initiatives,” stated Mr. Calvo. “We launched HCS101, an introductory 4-day program earlier this year and the customer response has been overwhelmingly positive. We will build upon this program using the Internet and our own website to provide expanded education and training programs,” said Calvo. “The collective experiences of this scientific team in HCS is unmatched”, stated Dr. Judy P. Masucci, Director of Marketing, who will lead the Center. “Our goal is to work closely with key outside collaborators and our own Technology and Product Development organization to develop a knowledge base in applying HCS solutions to both drug discovery and systems biology research efforts in pharmaceutical, biotechnology and academic markets,” said Dr. Masucci. Cellomics, Inc. is pioneering the field of cellular knowledge extraction. Its unique technology integrates fluorescence-based reagents, cell lines, multi-parametric assays, HCS instrumentation (both fixed end-point and kinetic systems), and informatics tools to achieve a flexible, broadly applicable platform for users in the life sciences. This automated platform, when applied to early drug discovery is proving to reduce the 'idea-to-discovery' cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as reducing the cycle time in basic research. Cellomics’ proprietary platform, including the ArrayScan® and KineticScan®HCS Readers, along with its vHCS™Discovery Toolbox software and automated analysis applications, are in use at multiple sites within all of the top fifteen pharmaceutical companies in the world, as well as leading pharmaceutical and biotechnology companies and academic centers globally. For further information please visit Cellomics at http://www.cellomics.com.
For further information, contact:
Judy P. Masucci, PhD Director, Marketing Cellomics, Inc. 100 Technology Drive Pittsburgh, PA 15219 412.770.2353 412.770.2450 (fax)
Last Updated ( Monday, 21 June 2004 )
Upcoming Events
December 13, 2008 ASCB 2008 Please visit our booth at the 49th Annual Meeting of the American Society for Cell Biology ...
Home 
Cellomics, Inc. announces the creation of a Center of Excellence
top